Claims for Patent: 4,616,658

Summary for Patent: 4,616,658

Title:	Non-radioactively labeled microspheres and use of same to measure blood flow
Abstract:	A safe and inexpensive method of measuring blood flow in experimental animals using non-radioactively labeled microspheres is provided. The microspheres may be comprised of a variety of materials, including latex and agarose, and may be labeled with colored dyes or by linkage to enzymes, plant enzymes being preferred because they do not occur naturally in an animal\'s system. After injection and circulation of the microspheres throughout the animal\'s system, blood flow to particular tissue may be measured by counting the number of microspheres in the tissue sample, the initial number of microspheres in the animal\'s blood stream having been measured shortly after injection. In the case of microspheres labeled with colored dyes, the spheres may be counted in tissue either after separation from the tissue or while still trapped in the tissue\'s capillaries. Techniques for separating the microspheres from blood and tissue are also provided.
Inventor(s):	Shell; William (Beverly Hills, CA), See; Jackie R. (Fullerton, CA)
Assignee:
Application Number:	06/706,151
Patent Claims:	1. A process for measuring blood flow in an animal comprising the steps of: (a) non-radioactively labeling microspheres; (b) introducing said labeled microspheres into the blood stream of an experimental animal; (c) determining the number of microspheres in a known volume of said animal's blood after introduction; (d) sacrificing said animal and recovering a portion of said animal's tissue; (e) determining the number of microspheres present in a known sample size of said tissue; (f) calculating blood flow to said tissue from the results of said determination. 2. A process as set forth in claim 1 wherein said microspheres are counted without separating them from said tissue. 3. A process as set forth in claim 1 wherein said microspheres are separated from said tissue before counting. 4. A process as set forth in claim 3 wherein said microspheres are separated from said tissue using collagenase. 5. A process as set forth in claim 3 wherein said non-radioactive label is a colored dye. 6. A process as set forth in claim 5 wherein said colored dye is oil soluble and water insoluble. 7. A process as set forth in claim 6 wherein said colored dye is selected from the group consisting of Oil Red O, Oil Red EGN, Oil Blue N., Sudan I, Sudan II, Sudan Black B, and Fat Brown RR. 8. A process as set forth in claim 3 wherein said non-radioactive label is an enzyme. 9. A process as set forth in claim 8 wherein the activity of said enzyme is measured using O-Phenylenediamine as a substrate. 10. A process as set forth in claim 8 wherein said enzyme is a plant enzyme. 11. A process as set forth in claim 10 wherein said plant enzyme is horseradish peroxidase. 12. A process as set forth in claim 10 wherein said enzyme is .beta.-amylase. 13. A process as set forth in claim 1 wherein said tissue is heart tissue. 14. A process as set forth in claim 1 wherein said microspheres are on the order of 7.mu. to 100.mu. in diameter. 15. A process as set forth in claim 14 wherein said microspheres are about 10.mu. in diameter. 16. A process for color dying microspheres comprising the steps of: (a) mixing said microspheres with a dye salt and a solvent so that the dye in said dye salt is taken up by said microspheres; (b) collecting the dyed microspheres of step (a); (c) suspending the dyed microspheres of step (b) in an emulsifier to accomplish disaggregation of the microspheres; (d) further disaggregating said dyed microspheres, if necessary; and (e) resuspending said dyed microspheres in a storage medium. 17. A process as set forth in claim 16 wherein said emulsifier is Triton X 100 or Tween 80. 18. A process as set forth in claim 16 wherein the further disaggregation of step (d) is accomplished by grinding said dyed microspheres. 19. A process as set forth in claim 16 wherein said storage medium is Triton X 100. 20. A process as set forth in claim 16 wherein said colored dye is oil soluble and water insoluble. 21. A process as set forth in claim 20 wherein said dye salt is the salt of a dye selected from the group consisting of Oil Red O, Oil Red EGN, Oil Blue N, Sudan I, Sudan II, Sudan Black B, and Fat Brown RR. 22. A process for separating microspheres from blood comprising the steps of: (a) mixing said blood with an anticoagulating agent to obtain anticoagulation of said blood; (b) mixing said blood with a hemolyzing solution to break up the red blood cells in said blood; (c) removing the hemoglobin from the blood contained in the solution of step (b); (d) concentrating the microspheres in the solution of step (c); and (e) dispersing the microspheres in the solution of step (d). 23. A process as set forth in claim 22 wherein said anticoagulating agent is heparin. 24. A process as set forth in claim 22 wherein said blood has a hematocrit of greater than around 30% and the ratio of hemolizing solution to blood is around 5:1. 25. A process as set forth in claim 22 wherein said blood has a hematocrit of less than around 30% and the ratio of hemolizing solution to blood is around 1:1. 26. A process for counting color dyed microspheres embedded in a tissue section comprising the steps of: (a) counting the number of microspheres within a statistically significant area of said tissue section; and (b) statistically determining the number of microspheres per unit volume of tissue from the counting results in step (a). 27. A process as set forth in claim 26 wherein the number of microspheres per unit volume of tissue is calculated by first determining the total area that must be viewed in order to observe a statistically significant predetermined number of microspheres, then multiplying said area by the thickness of said tissue sample. 28. A process as set forth in claim 27 wherein said statistically significant predetermined number of microspheres is around 20. 29. A process as set forth in claim 26 wherein said tissue section is a heart tissue section.

Details for Patent 4,616,658

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2039-03-29